Inventor · disambiguated record
Yufen Zhao
Also filed as: ZHAO YUFEN
30 granted patents·5 pending applications·190 citations·filing 2001–2023
96Inventor score
Files withBRISTOL MYERS SQUIBB CO25FINK BRIAN E3SEINDA PHARMACEUTICAL GUANGZHOU CORP2GUANGDONG PHOBIOLOGY TECH CO LTD1INST PHARM & TOXICOLOGY AMMS1
Top patents by PatentIndex Score
35 records- 0194US9273057B2Imidazotriazinecarbonitriles useful as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Mar 1, 2016·29 cites·15 claims
- 0292US9273014B2Bis(fluoroalkyl)-1,4-benzodiazepinone compounds and prodrugs thereofBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Mar 1, 2016·14 cites·11 claims
- 0391US6916809B2Heterocyclic acridone inhibitors of IMPDH enzymeBRISTOL MYERS SQUIBB CO·Filed 2002·Granted Jul 12, 2005·61 cites·9 claims
- 0489US8252795B2Imidazopyridazinecarbonitriles useful as kinase inhibitorsFINK BRIAN E·Filed 2009·Granted Aug 28, 2012·19 cites·11 claims
- 0589US7297695B2Pyrrolotriazine compounds as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Nov 20, 2007·9 cites·4 claims
- 0688US7151176B2Pyrrolotriazine compoundsBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Dec 19, 2006·12 cites·5 claims
- 0786US8999918B2Bis(fluoroalkyl)-1,4-benzodiazepinone compounds and prodrugs thereofBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Apr 7, 2015·9 cites·19 claims
- 0883US9708316B2TGFβR antagonistsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Jul 18, 2017·5 cites·13 claims
- 0982US11427610B2Cyclic dinucleotides as anticancer agentsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Aug 30, 2022·2 cites·23 claims
- 1079US9556178B2Imidazotriazinecarbonitriles useful as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Jan 31, 2017·3 cites·7 claims
- 1179US9492460B2Carbazole compounds useful as bromodomain inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Nov 15, 2016·4 cites·15 claims
- 1279US8940736B2Imidazotriazinecarbonitriles useful as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Jan 27, 2015·3 cites·19 claims
- 1378US7514435B2Pyrrolotriazine kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Apr 7, 2009·3 cites·6 claims
- 1478US7141571B2Pyrrolotriazine compounds as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Nov 28, 2006·8 cites·4 claims
- 1577US11660311B2Cyclic dinucleotides as anticancer agentsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted May 30, 2023·2 cites·17 claims
- 1676US7846931B2Pyrrolotriazine compounds as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2008·Granted Dec 7, 2010·1 cites·1 claims
- 1769US8389527B2Substituted imidazopyridazines useful as kinase inhibitorsFINK BRIAN E·Filed 2009·Granted Mar 5, 2013·1 cites·12 claims
- 1865US7163917B2Synthesis method of alanylglutamineZHAO YUFEN·Filed 2003·Granted Jan 16, 2007·2 cites·15 claims
- 1964US2024148818A1Ophthalmic pharmaceutical composition and its preparation methods and applicationsSEINDA PHARMACEUTICAL GUANGZHOU CORP·Filed 2023·Application pending·0 cites
- 2061US11339185B2Cyclic dinucleotides as anticancer agentsBRISTOL MYERS SQUIBB CO·Filed 2019·Granted May 24, 2022·0 cites·11 claims
- 2161US6953780B2Endothelin antagonistINST PHARM & TOXICOLOGY AMMS·Filed 2001·Granted Oct 11, 2005·3 cites·9 claims
- 2258US10519187B2Cyclic dinucleotides as anticancer agentsBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Dec 31, 2019·0 cites·70 claims
- 2357US9371328B2Imidazopyridazinecarbonitriles useful as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Jun 21, 2016·0 cites·8 claims
- 2454US12448340B2Isobaric stable isotope-containing phosphorylated protein labeling reagent, and preparation method and application thereofGUANGDONG PHOBIOLOGY TECH CO LTD·Filed 2021·Granted Oct 21, 2025·0 cites·14 claims
- 2554US2011039838A1Pyrrolotriazine compounds as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2010·Application pending·0 cites
- 2653US2016108050A1Imidazotriazinecarbonitriles useful as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2015·Application pending·0 cites
- 2751US9242941B2Alkyl, fluoroalkyl-1,4-benzodiazepinone compoundsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Jan 26, 2016·0 cites·8 claims
- 2851US2012283241A1Imidazopyridazinecarbonitriles useful as kinase inhibitorsFINK BRIAN E·Filed 2012·Application pending·0 cites
- 2951US2021030833A1Ophthalmic pharmaceutical composition, preparation method therefor and application thereofSEINDA PHARMACEUTICAL GUANGZHOU CORP·Filed 2019·Application pending·0 cites
- 3049US7312209B2Acridone inhibitors of IMPDH enzymeBRISTOL MYERS SQUIBB CO·Filed 2002·Granted Dec 25, 2007·0 cites·29 claims
- 3147US8466171B2Fused heterocyclic compounds useful as modulators of nuclear hormone receptor functionSHAN WEIFANG·Filed 2008·Granted Jun 18, 2013·0 cites·3 claims
- 3246US9427442B2Fluoroalkyl and fluorocycloalkyl 1,4-benzodiazepinone compoundsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Aug 30, 2016·0 cites·7 claims
- 3346US7358256B2ATP competitive kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Apr 15, 2008·0 cites·2 claims
- 3444US10744150B2Cyclic dinucleotides as anticancer agentsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Aug 18, 2020·0 cites·54 claims
- 3542US8067582B2Fused heterocyclic compounds useful as modulators of nuclear hormone receptor functionNORRIS DEREK J·Filed 2008·Granted Nov 29, 2011·0 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when Yufen Zhao files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →